Summer, 2005

A spin-off company, Prevtec microbia, was recently derived from the Université de Montréal. Prevtec, co-founded by Drs Fairbrother and Nadeau, is presently undertaking the steps for licensing by the Canadian Food Inspection Agency of a live vaccine for the control of postweaning diarrhea in pigs. This vaccine is based on a technology which was developed as part of the research carried out in the EcL.

For more information, see the Vecteur Vol 4 No 2 April, 2005 (French only)

Back to News